Two years postconversion from a prograf-based regimen to a once-daily tacrolimus extended-release formulation in stable kidney transplant recipients.

@article{Alloway2007TwoYP,
  title={Two years postconversion from a prograf-based regimen to a once-daily tacrolimus extended-release formulation in stable kidney transplant recipients.},
  author={Rita R. Alloway and Steven Steinberg and Kassem Khalil and Sita M Gourishankar and Joshua Miller and Douglas Everett Norman and Sundaram Hariharan and John D. Pirsch and Arthur Matas and Jeffrey Zaltzman and Kathleen Wisemandle and William E. Fitzsimmons and M. Roy First},
  journal={Transplantation},
  year={2007},
  volume={83 12},
  pages={1648-51}
}
Tacrolimus extended-release (XL) is a once-daily formulation recently developed to reduce the frequency of dosing for patients currently using the twice-a-day formulation of tacrolimus (TAC). As reported previously, 67 kidney transplant recipients were safely converted (1:1 mg basis, total daily dose) from TAC twice-a-day to XL once-daily in the morning and were maintained on an am dosing regimen of XL using the same therapeutic monitoring and patient care techniques currently employed with TAC… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 29 extracted citations

Similar Papers

Loading similar papers…